FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4285208352> ?p ?o ?g. }

• W4285208352 abstract "What are the data and trends on ART and IUI cycle numbers and their outcomes, and on fertility preservation (FP) interventions, reported in 2018 as compared to previous years?The 22nd ESHRE report shows a continued increase in reported numbers of ART treatment cycles and children born in Europe, a decrease in transfers with more than one embryo with a further reduction of twin delivery rates (DRs) as compared to 2017, higher DRs per transfer after fresh IVF or ICSI cycles (without considering freeze-all cycles) than after frozen embryo transfer (FET) with higher pregnancy rates (PRs) after FET and the number of reported IUI cycles decreased while their PR and DR remained stable.ART aggregated data generated by national registries, clinics or professional societies have been gathered and analysed by the European IVF-monitoring Consortium (EIM) since 1997 and reported in 21 manuscripts published in Human Reproduction and Human Reproduction Open.Data on medically assisted reproduction (MAR) from European countries are collected by EIM for ESHRE on a yearly basis. The data on treatment cycles performed between 1 January and 31 December 2018 were provided by either national registries or registries based on initiatives of medical associations and scientific organizations or committed persons of 39 countries.Overall, 1422 clinics offering ART services in 39 countries reported a total of more than 1 million (1 007 598) treatment cycles for the first time, including 162 837 with IVF, 400 375 with ICSI, 309 475 with FET, 48 294 with preimplantation genetic testing, 80 641 with egg donation (ED), 532 with IVM of oocytes and 5444 cycles with frozen oocyte replacement (FOR). A total of 1271 institutions reported data on IUI cycles using either husband/partner's semen (IUI-H; n = 148 143) or donor semen (IUI-D; n = 50 609) in 31 countries and 25 countries, respectively. Sixteen countries reported 20 994 interventions in pre- and post-pubertal patients for FP including oocyte, ovarian tissue, semen and testicular tissue banking.In 21 countries (21 in 2017) in which all ART clinics reported to the registry, 410 190 treatment cycles were registered for a total population of ∼ 300 million inhabitants, allowing a best estimate of a mean of 1433 cycles performed per million inhabitants (range: 641-3549). Among the 39 reporting countries, for IVF, the clinical PR per aspiration slightly decreased while the PR per transfer remained similar compared to 2017 (25.5% and 34.1% in 2018 versus 26.8% and 34.3% in 2017). In ICSI, the corresponding rates showed similar evolutions in 2018 compared to 2017 (22.5% and 32.1% in 2018 versus 24.0% and 33.5% in 2017). When freeze-all cycles were not considered for the calculations, the clinical PRs per aspiration were 28.8% (29.4% in 2017) and 27.3% (27.3% in 2017) for IVF and ICSI, respectively. After FET with embryos originating from own eggs, the PR per thawing was 33.4% (versus 30.2% in 2017), and with embryos originating from donated eggs 41.8% (41.1% in 2017). After ED, the PR per fresh embryo transfer was 49.6% (49.2% in 2017) and per FOR 44.9% (43.3% in 2017). In IVF and ICSI together, the trend towards the transfer of fewer embryos continues with the transfer of 1, 2, 3 and ≥4 embryos in 50.7%, 45.1%, 3.9% and 0.3% of all treatments, respectively (corresponding to 46.0%, 49.2%. 4.5% and 0.3% in 2017). This resulted in a reduced proportion of twin DRs of 12.4% (14.2% in 2017) and similar triplet DR of 0.2%. Treatments with FET in 2018 resulted in twin and triplet DRs of 9.4% and 0.1%, respectively (versus 11.2% and 0.2%, respectively in 2017). After IUI, the DRs remained similar at 8.8% after IUI-H (8.7% in 2017) and at 12.6% after IUI-D (12.4% in 2017). Twin and triplet DRs after IUI-H were 8.4% and 0.3%, respectively (in 2017: 8.1% and 0.3%), and 6.4% and 0.2% after IUI-D (in 2017: 6.9% and 0.2%). Among 20 994 FP interventions in 16 countries (18 888 in 13 countries in 2017), cryopreservation of ejaculated sperm (n = 10 503, versus 11 112 in 2017) and of oocytes (n = 9123 versus 6588 in 2017) were the most frequently reported.The results should be interpreted with caution as data collection systems and completeness of reporting vary among European countries. Some countries were unable to deliver data about the number of initiated cycles and/or deliveries.The 22nd ESHRE data collection on ART, IUI and FP interventions shows a continuous increase of reported treatment numbers and MAR-derived livebirths in Europe. Although it is the largest data collection on MAR in Europe, further efforts towards optimization of both the collection and reporting, with the aim of improving surveillance and vigilance in the field of reproductive medicine, are awaited.The study has received no external funding and all costs are covered by ESHRE. There are no competing interests." @default.
• W4285208352 created "2022-07-14" @default.
• W4285208352 creator A5002712843 @default.
• W4285208352 creator A5037649823 @default.
• W4285208352 creator A5046492899 @default.
• W4285208352 creator A5065723385 @default.
• W4285208352 creator A5067423949 @default.
• W4285208352 creator A5079728714 @default.
• W4285208352 creator A5080962523 @default.
• W4285208352 creator A5086328263 @default.
• W4285208352 creator A5087021385 @default.
• W4285208352 creator A5088727927 @default.
• W4285208352 date "2022-01-01" @default.
• W4285208352 modified "2023-10-17" @default.
• W4285208352 title "ART in Europe, 2018: results generated from European registries by ESHRE" @default.
• W4285208352 cites W1882638238 @default.
• W4285208352 cites W2110927890 @default.
• W4285208352 cites W2153299006 @default.
• W4285208352 cites W2157347582 @default.
• W4285208352 cites W2231632530 @default.
• W4285208352 cites W2508180437 @default.
• W4285208352 cites W2610645888 @default.
• W4285208352 cites W2741632770 @default.
• W4285208352 cites W2766802525 @default.
• W4285208352 cites W3005014526 @default.
• W4285208352 cites W3006902664 @default.
• W4285208352 cites W3046588085 @default.
• W4285208352 cites W3100377772 @default.
• W4285208352 cites W3184184652 @default.
• W4285208352 cites W3192215542 @default.
• W4285208352 cites W4205754343 @default.
• W4285208352 cites W4256255060 @default.
• W4285208352 doi "https://doi.org/10.1093/hropen/hoac022" @default.
• W4285208352 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35795850" @default.
• W4285208352 hasPublicationYear "2022" @default.
• W4285208352 type Work @default.
• W4285208352 citedByCount "61" @default.
• W4285208352 countsByYear W42852083522022 @default.
• W4285208352 countsByYear W42852083522023 @default.
• W4285208352 crossrefType "journal-article" @default.
• W4285208352 hasAuthorship W4285208352A5002712843 @default.
• W4285208352 hasAuthorship W4285208352A5037649823 @default.
• W4285208352 hasAuthorship W4285208352A5046492899 @default.
• W4285208352 hasAuthorship W4285208352A5065723385 @default.
• W4285208352 hasAuthorship W4285208352A5067423949 @default.
• W4285208352 hasAuthorship W4285208352A5079728714 @default.
• W4285208352 hasAuthorship W4285208352A5080962523 @default.
• W4285208352 hasAuthorship W4285208352A5086328263 @default.
• W4285208352 hasAuthorship W4285208352A5087021385 @default.
• W4285208352 hasAuthorship W4285208352A5088727927 @default.
• W4285208352 hasBestOaLocation W42852083521 @default.
• W4285208352 hasConcept C131872663 @default.
• W4285208352 hasConcept C144024400 @default.
• W4285208352 hasConcept C149923435 @default.
• W4285208352 hasConcept C160099875 @default.
• W4285208352 hasConcept C18903297 @default.
• W4285208352 hasConcept C2777688143 @default.
• W4285208352 hasConcept C2778279030 @default.
• W4285208352 hasConcept C2779234561 @default.
• W4285208352 hasConcept C2908647359 @default.
• W4285208352 hasConcept C29456083 @default.
• W4285208352 hasConcept C500014431 @default.
• W4285208352 hasConcept C512399662 @default.
• W4285208352 hasConcept C518429986 @default.
• W4285208352 hasConcept C54355233 @default.
• W4285208352 hasConcept C59659247 @default.
• W4285208352 hasConcept C71924100 @default.
• W4285208352 hasConcept C86803240 @default.
• W4285208352 hasConcept C99454951 @default.
• W4285208352 hasConceptScore W4285208352C131872663 @default.
• W4285208352 hasConceptScore W4285208352C144024400 @default.
• W4285208352 hasConceptScore W4285208352C149923435 @default.
• W4285208352 hasConceptScore W4285208352C160099875 @default.
• W4285208352 hasConceptScore W4285208352C18903297 @default.
• W4285208352 hasConceptScore W4285208352C2777688143 @default.
• W4285208352 hasConceptScore W4285208352C2778279030 @default.
• W4285208352 hasConceptScore W4285208352C2779234561 @default.
• W4285208352 hasConceptScore W4285208352C2908647359 @default.
• W4285208352 hasConceptScore W4285208352C29456083 @default.
• W4285208352 hasConceptScore W4285208352C500014431 @default.
• W4285208352 hasConceptScore W4285208352C512399662 @default.
• W4285208352 hasConceptScore W4285208352C518429986 @default.
• W4285208352 hasConceptScore W4285208352C54355233 @default.
• W4285208352 hasConceptScore W4285208352C59659247 @default.
• W4285208352 hasConceptScore W4285208352C71924100 @default.
• W4285208352 hasConceptScore W4285208352C86803240 @default.
• W4285208352 hasConceptScore W4285208352C99454951 @default.
• W4285208352 hasFunder F4320327370 @default.
• W4285208352 hasIssue "3" @default.
• W4285208352 hasLocation W42852083521 @default.
• W4285208352 hasLocation W42852083522 @default.
• W4285208352 hasLocation W42852083523 @default.
• W4285208352 hasLocation W42852083524 @default.
• W4285208352 hasLocation W42852083525 @default.
• W4285208352 hasLocation W42852083526 @default.
• W4285208352 hasLocation W42852083527 @default.
• W4285208352 hasLocation W42852083528 @default.
• W4285208352 hasLocation W42852083529 @default.
• W4285208352 hasOpenAccess W4285208352 @default.
• W4285208352 hasPrimaryLocation W42852083521 @default.

• next